Product Information
POTASSIUM CITRATE ER 15 MEQ TB is a generic product labeled by Strides Pharma Inc., priced at $0.1804 per EA under NDC 42543040801. Its NADAC has been published 465 times since Sep 27, 2017.
FDA first approved this application on Sep 11, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15 meq/1
Manufacturer
Strides Pharma Inc.NDC
42543040801
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
POTASSIUM CITRATEApproval Type
Generic (ANDA)
FDA Application
ANDA206813FDA Approved
9/11/2017
TE Code
AB
On Market Since
11/1/2017
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CITRATE ER 15 MEQ TB has been published 465 times since Sep 27, 2017, and over the history we have for it it has declined 90.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1804 per EA |
|---|---|
| All-time high | $1.8437 (Mar 14, 2018) |
| All-time low | $0.1722 (Jul 17, 2024) |
| 52-week high | $0.2197 |
| 52-week low | $0.1796 |
| Median price | $0.6555 |
| Average price | $0.7776 |
| Largest weekly change | +69.2% (May 17, 2023) |
| Weeks tracked | 465 |
| Tracking since | Sep 27, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the POTASSIUM CITRATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of POTASSIUM CITRATE ER 15 MEQ TB?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CITRATE ER 15 MEQ TB, manufactured by Strides Pharma Inc., is $0.1804 per EA (NDC 42543040801), effective Aug 19, 2026.
How has the price of POTASSIUM CITRATE ER 15 MEQ TB changed over time?
Over the history we have for it, the NADAC for POTASSIUM CITRATE ER 15 MEQ TB has declined 90.2%. It has been tracked across 465 weekly CMS publications since Sep 27, 2017.
What are the highest and lowest recorded NADAC prices for POTASSIUM CITRATE ER 15 MEQ TB?
Since Sep 27, 2017, the NADAC for POTASSIUM CITRATE ER 15 MEQ TB has ranged from a low of $0.1722 (Jul 17, 2024) to a high of $1.8437 (Mar 14, 2018), with a median of $0.6555 per EA.
Are there cheaper alternatives to POTASSIUM CITRATE ER 15 MEQ TB?
No other NADAC-published product currently shares the active ingredient and strength of POTASSIUM CITRATE ER 15 MEQ TB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures POTASSIUM CITRATE ER 15 MEQ TB?
POTASSIUM CITRATE ER 15 MEQ TB (NDC 42543040801) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.